https://www.selleckchem.com/pr....oducts/chk2-inhibito
40% women, .001) and using gamete or gonadal cryopreservation (71% men vs. 15% women, .001). Patients with brain tumors and patients without a pretreatment desire for children were less likely to report being informed about potential impact on their fertility and about fertility preservation. In addition, being born outside Sweden was negatively associated with reported receipt of information about impact of cancer treatment on fertility. Among women, older age (35 years), non-heterosexuality and being a p
Like
Comment
Share
